# Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders

> **NCT00579137** · PHASE1,PHASE2 · TERMINATED · sponsor: **Baylor College of Medicine** · enrollment: 3 (actual)

## Conditions studied

- Severe Combined Immunodeficiency Disease
- Severe Primary Immunodeficiency Disorder
- Undefined T Cell Deficiency Disorder
- Wiskott-Aldrick Syndrome

## Interventions

- **BIOLOGICAL:** Campath -1H
- **DRUG:** Fludarabine
- **BIOLOGICAL:** Anti-CD45
- **PROCEDURE:** Stem cell infusion

## Key facts

- **NCT ID:** NCT00579137
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** slow accrual
- **Last updated:** 2013-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00579137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00579137, "Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00579137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*